Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Janux Therapeutics, Inc. - Common Stock (NQ:JANX)

13.51 +0.14 (+1.05%)
Streaming Delayed Price Updated: 10:39 AM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Janux Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come? ↗
These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank? 
Via InvestorPlace
News headline image
A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts ↗
 
Via Benzinga
News headline image
Why Janux Therapeutics Stock Is Crushing It This Week ↗
Janux's silence about a potential acquisition deal could be golden. 
Via The Motley Fool
News headline image
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. 
Via Benzinga
News headline image
Forecasting The Future: 4 Analyst Projections For Janux Therapeutics ↗
 
Via Benzinga
News headline image
Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday? ↗
Janux Therapeutics may be up for sale amid interest from major pharmaceutical firms. With shares quadrupling this year and a successful equity offering, Janux is making waves in the industry. The... 
Via Benzinga
News headline image
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. 
Via Benzinga
Topics Stocks
News headline image
Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options ↗
Novartis snagged a licensing deal with Arvinas worth up to $1.16 billion, while Janux is said to be exploring its options. 
Via Investor's Business Daily
News headline image
Why Janux Therapeutics Stock Soared as the Market Sagged Today ↗
One of the hotter biotech companies on the scene might be changing owners before long. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst ↗
Cantor Fitzgerald's coverage on Janux Therapeutics and its TRACTr/TRACir platform targeting diverse tumor antigens and cancer types. Analysts anticipate substantial growth potential driven by JANX007,... 
Via Benzinga
News headline image
JANX Stock Earnings: Janux Therapeutics Beats EPS, Beats Revenue for Q4 2023 ↗
JANX stock results show that Janux Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
2 Stocks That Have More Than Tripled This Year: Are They Buys? ↗
Don't jump on the bandwaggon too quickly. 
Via The Motley Fool
News headline image
B of A Securities Maintains Buy Rating for Janux Therapeutics: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
From Janux Therapeutics
Via Business Wire
News headline image
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. 
Via Benzinga
News headline image
5 Stocks That More Than Doubled In February ↗
U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade. Meanwhile, the Dow 
Via Talk Markets
Topics Stocks
News headline image
After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy? ↗
The biotech tantalized investors with a very promising data update. 
Via The Motley Fool
News headline image
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
From Janux Therapeutics
Via Business Wire
News headline image
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares? ↗
The company reported in-line sales for the fourth quarter, but shares soared by double digits. 
Via Investor's Business Daily
News headline image
Janux Therapeutics Announces Proposed Public Offering of Common Stock
From Janux Therapeutics
Via Business Wire
News headline image
Stocks Mixed As Consumer Confidence Falls ↗
Stocks are mixed midday, after the most recent batch of economic data. 
Via Talk Markets
News headline image
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings ↗
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28% to 16,021.41.... 
Via Benzinga
Topics Stocks
News headline image
S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday? ↗
On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations. 
Via Benzinga
Topics Stocks
News headline image
Cancer-Focused Janux Therapeutics Stock Remains Undervalued Despite Price Surge After Study Data: Analyst ↗
JANX Therapeutics' updates in cancer treatment: JANX007 shows promising PSA declines in prostate cancer trials, while JANX008 exhibits encouraging clinical activity in solid tumors. 
Via Benzinga
News headline image
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,915.65 while the NASDAQ rose 0.15% to 15,999.50. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Janux Therapeutics Nearly Triples As Prostate Cancer Drug Shows 'Significant Opportunity' ↗
The company is working on a treatment for metastatic castration-resistant prostate cancer. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.